Holen Sie sich die Stockscreener-App
122.68
0.41%
-0.50
Vorhandelsmarkt:
122.56
-0.12
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$123.18
Offen:
$122.9
24-Stunden-Volumen:
8.65M
Relative Volume:
0.74
Marktkapitalisierung:
$303.31B
Einnahmen:
$64.93B
Nettoeinkommen (Verlust:
$18.26B
KGV:
16.86
EPS:
7.2751
Netto-Cashflow:
$12.36B
1W Leistung:
+1.50%
1M Leistung:
+4.76%
6M Leistung:
+40.21%
1J Leistung:
+49.77%
1-Tages-Spanne:
$121.35
$124.00
1-Wochen-Bereich:
$116.50
$124.00
52-Wochen-Spanne:
$73.31
$125.14
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
122.68 | 304.55B | 64.93B | 18.26B | 12.36B | 7.2751 |
LLY
Lilly Eli Co
|
955.19 | 851.64B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
241.31 | 581.20B | 94.19B | 26.80B | 19.70B | 11.05 |
ABBV
Abbvie Inc
|
212.40 | 374.25B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
204.99 | 316.79B | 58.80B | 10.24B | 8.98B | 3.2788 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-20 | Eingeleitet | Barclays | Overweight |
| 2026-02-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032 - GlobeNewswire Inc.
BOCHK Asset Management Ltd Invests $1.90 Million in Merck & Co., Inc. $MRK - MarketBeat
Douglas Lane & Associates LLC Has $59.56 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Leerink raises Merck & Co. Inc. (MRK) price target, sees upside from cancer drug - MSN
Merck Beats 295 Zostavax Suits Over Missed Deadlines - Law360
Merck & Co., Inc. stock: Undervalued by 39% despite strong gains? - AD HOC NEWS
Merck & Co.'s Quarterly Earnings Preview: What You Need to Know - FinancialContent
OFI Invest Asset Management Sells 27,934 Shares of Merck & Co., Inc. $MRK - MarketBeat
Newman Dignan & Sheerar Inc. Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. (NYSE:MRK) Offers a Durable Dividend Backed by Strong Earnings - ChartMill
Jackson Square Capital LLC Acquires Shares of 9,701 Merck & Co., Inc. $MRK - MarketBeat
Franklin Street Advisors Inc. NC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Addenda Capital Inc. - MarketBeat
Merck & Co Inc Stock (MRK) Moved Up by 3.18% on Apr 8: Facts Behind the Movement - TradingKey
[ARS] Merck & Co., Inc. SEC Filing - Stock Titan
Merck & Co Inc CEO Robert M. Davis 2025 Total Compensation $20.8 Million - TradingView
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
How Merck slashed its bid for Terns Pharmaceuticals by $1B after reviewing cancer drug trial data - The Business Journals
Merck & Co., Inc. $MRK Shares Sold by Yousif Capital Management LLC - MarketBeat
19,470 Shares in Merck & Co., Inc. $MRK Acquired by Jefferson Bridge Capital LLC - MarketBeat
Merck (MRK) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Merck’s (NYSE:MRK) Terns Deal And S&P 500 Valuation Impact Explained - Kalkine Media
Is Merck & Co. (MRK) One of the Best Consistent Dividend Stocks to Buy Right Now? - Insider Monkey
Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data ReviewMerck & Co (NYSE:MRK), Terns Ph - Benzinga
What's Going On With Merck Stock Tuesday? - Benzinga
Merck (MRK) Initiates Tender Offer for Terns Pharmaceuticals - GuruFocus
Strong Results Lifted Merck & Co (MRK) in Q4 - Yahoo Finance
Is It Too Late to Buy Costco or Merck? Are These Defensive Stocks Overbought? - 24/7 Wall St.
Merck (MRK) Collaborates in Promising Trial of Personalized Canc - GuruFocus
Merck's experimental HIV prevention pill could be made for less than $5 a year, researchers say - statnews.com
Merck begins tender offer to buy Terns Pharmaceuticals (MRK:NYSE) - Seeking Alpha
Merck begins tender offer to acquire Terns Pharmaceuticals, Inc. - marketscreener.com
Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share - StreetInsider
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Business Wire
Terns rebuffed a higher bid before selling to Merck - Yahoo Finance
Merck (NYSE: TERN) to acquire Terns for $53.00 per share cash - Stock Titan
Merck to stop Gardasil production in Durham - MSN
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Rathbones Group PLC - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Quilter Plc - MarketBeat
JPMorgan Adjusts Price Target on Merck & Co. to $135 From $125, Maintains Overweight Rating - marketscreener.com
Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc. - MarketBeat
Town & Country Bank & Trust CO dba First Bankers Trust CO Has $3.37 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Nvwm LLC Acquires 31,854 Shares of Merck & Co., Inc. $MRK - marketbeat.com
JB Capital LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Trimmed by Florida Trust Wealth Management Co - MarketBeat
Merck & Co., Inc. (MRK) stock price, news, quote and history - Yahoo Finance UK
Perpetual Ltd Purchases 9,261 Shares of Merck & Co., Inc. $MRK - MarketBeat
SS&H Financial Advisors Inc. Acquires 12,200 Shares of Merck & Co., Inc. $MRK - MarketBeat
SteelPeak Wealth LLC Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Quintet Private Bank Europe S.A. - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):